Post Menopausal Osteoporosis Market Report 2023: Epidemiology, Industry Trends, Size, Share and Forecast to 2033

IMARC Group has recently released a report titled "Post Menopausal Osteoporosis Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)" that presents a comprehensive assessment of the post menopausal osteoporosis market size, latest trends, and growth forecast. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market scenario, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the post menopausal osteoporosis market.

Post menopausal osteoporosis refers to a type of osteoporosis that develops in women after menopause. Osteoporosis is an ailment marked by low bone density and structural deterioration of bone tissue, resulting in increased fragility as well as a higher risk of fractures. Some of the common symptoms linked with the condition include back pain, loss of height over time, a stooped posture (kyphosis), susceptibility to fractures, especially in the wrist, hip, and spine, etc. The diagnosis of post menopausal osteoporosis involves a combination of clinical assessment, dual-energy X-ray absorptiometry (DXA), laboratory blood tests, and vertebral imaging.

Request a Free Sample Report : https://www.imarcgroup.com/post-menopausal-osteoporosis-market/requestsample

The growing instances of decline in estrogen levels during menopause that lead to an imbalance between bone formation and bone resorption, thereby resulting in a net loss of bone density, are primarily augmenting the post menopausal osteoporosis market. Moreover, the increasing incidence of various associated risk factors, such as genetic predisposition, inadequate intake of calcium and vitamin D, sedentary lifestyle, prolonged use of corticosteroids, excessive alcohol consumption, etc., is also catalyzing the market growth.

Besides this, the escalating utilization of oral bisphosphonates to inhibit bone resorption and minimize the likelihood of fractures in patients is acting as another significant growth-inducing factor. Furthermore, the bolstering need for novel sequential therapies that utilize anabolic agents and antiresorptive medications for optimizing bone formation and reducing bone loss is positively impacting the market growth. Additionally, the rising popularity of the trabecular bone score (TBS) imaging technique, since it enables the evaluation of the microarchitecture of trabecular bone, offering valuable insights into bone quality, fracture risk, and response to treatment, is expected to drive the post menopausal osteoporosis market in the coming years.

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the post menopausal osteoporosis market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the post menopausal osteoporosis market
Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/request?type=report&id=7996&flag=C

Browse the Latest Research Report:

Mantle Cell Lymphoma Market Report: https://www.imarcgroup.com/mantle-cell-lymphoma-market

Ischemic Stroke Market Report: https://www.imarcgroup.com/ischemic-stroke-market

Nocturia Market Report: https://www.imarcgroup.com/nocturia-market

Oral Mucositis Market Report: https://www.imarcgroup.com/oral-mucositis-market

Key Questions Answered in this Report:

How has the post menopausal osteoporosis market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the post menopausal osteoporosis market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the post menopausal osteoporosis market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.